“Barrett’s Esophagus: Changing Algorithms in Patient Management”
Event Navigation
Medtronic* & Saxe Communications present…“Barrett’s Esophagus: Changing Algorithms in Patient Management”
Barrett’s esophagus (BE) is a common, costly disease associated with a low, but real, risk of esophageal adenocarcinoma. Despite the common nature of this condition, care for patients with BE is inconsistent and often suboptimal, with wide variations reported. In this presentation, we will discuss the best management of BE patients, with a focus on new data in 3 areas: Chemoprevention, non-endoscopic screening, and endoscopic therapy of BE.
Learning Objectives | Upon completion of this educational activity, the participant should be able to:
- Describe new data in chemoprevention of esophageal neoplasia.
- Understand the utility of non-endoscopic methods of screening for Barrett’s esophagus.
- Recognize appropriate patients for endoscopic therapy of Barrett’s esophagus.
Presenter:
Nicholas J. Shaheen, M.D., MPH | Chief, Division of Gastroenterology & Hepatology | University of North Carolina School of Medicine, Chapel Hill
Target Audience: Physicians & Nurses
Continuing Education for Physicians and Nurses
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your Ce Source and Saxe Healthcare Communications. Your CE Source is accredited by ACCME for 1 AMA PRA Category 1 Credit each.This education activity is approved for 1.0 contact hour each. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.
Questions should be directed to Saxe Communications: webinair@saxecommunications.com
There is no cost for this program.
Educational support provided by Medtronic*.
* NOTE: This is a supplier and/or industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
